Table 4. Comparison of average anthropometric factors (distribution of abdominal fat and BMI) and classified by hormone in only breast cancer patients.
| Hormone | Subject | Score | No. (%) of participants | Total abdominal fat (mm2) | Visceral fat (mm2) | Subcutaneous fat (mm2) | Abdominal fat ratio (%) | BMI | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | P | Average | P | Average | P | Average | P | Average | P | ||||||||
| ER | Total patients | Negative | 72 (30.8) | 24,596.6 | 0.21 | 9,028.6 | 0.11 | 15,567.9 | 0.47 | 33.9 | 0.12 | 23.6 | 0.98 | ||||
| Positive | 162 (69.2) | 22,775.1 | 7,778.9 | 14,996.1 | 31.9 | 23.6 | |||||||||||
| Pre-menopausal | Negative | 30 (23.3) | 19,049.7 | 0.63 | 5,936.8 | 0.67 | 1,312.8 | 0.63 | 29.0 | 0.41 | 22.4 | 0.64 | |||||
| Positive | 99 (76.7) | 19,939.3 | 6,305.1 | 13,634.1 | 19.1 | 22.7 | |||||||||||
| Post-menopausal | Negative | 42 (40.0) | 28,384.6 | 0.81 | 11,140.0 | 0.60 | 17,244.6 | 0.87 | 37.3 | 0.72 | 24.5 | 0.25 | |||||
| Positive | 63 (60.0) | 27,951.6 | 10,539.8 | 17,411.8 | 36.5 | 25.2 | |||||||||||
| PR | Total patients | Negative | 98 (41.9) | 24,822.8 | 0.06 | 9,153.9 | 0.02 | 15,668.8 | 0.27 | 34.4 | 0.06 | 23.7 | 0.78 | ||||
| Positive | 136 (58.1) | 22,362.2 | 7,515.1 | 14,847.1 | 31.3 | 23.6 | |||||||||||
| Pre-menopausal | Negative | 42 (32.3) | 19,948.8 | 0.86 | 6,414.5 | 0.74 | 13,534.3 | 0.98 | 29.8 | 0.33 | 22.3 | 0.49 | |||||
| Positive | 88 (67.7) | 19,652.2 | 6,142.0 | 13,510.2 | 28.8 | 22.8 | |||||||||||
| Post-menopausal | Negative | 56 (53.8) | 28,290.9 | 0.83 | 11,103.1 | 0.51 | 17,187.7 | 0.74 | 37.6 | 0.41 | 24.7 | 0.44 | |||||
| Positive | 48 (46.2) | 27,953.9 | 10,446.1 | 17,507.8 | 36.0 | 25.2 | |||||||||||
| HER2 | Total patients | Negative | 156 (68.7) | 24,101.5 | 0.14 | 8,597.7 | 0.27 | 15,503.8 | 0.12 | 33.4 | 0.43 | 24.0 | 0.28 | ||||
| Positive | 71 (31.3) | 22,204.1 | 7,553.6 | 14,651.1 | 30.9 | 23.1 | |||||||||||
| Pre-menopausal | Negative | 89 (71.2) | 21,063.4 | 0.00 | 6,905.0 | 0.00 | 14,158.3 | 0.03 | 30.3 | 0.02 | 23.0 | 0.06 | |||||
| Positive | 36 (28.8) | 16,468.4 | 4,535.6 | 1,193.7 | 26.0 | 21.9 | |||||||||||
| Post-menopausal | Negative | 67 (65.7) | 28,137.2 | 0.82 | 10,846.1 | 0.84 | 17,291.0 | 0.53 | 37.3 | 0.58 | 25.3 | 0.65 | |||||
| Positive | 35 (34.3) | 28,103.8 | 10,656.6 | 17,447.1 | 35.9 | 24.3 | |||||||||||
ER and PR were classified as Allred score: ≥3= positive, 0–2= negative; HER2 was classified: ≥3= positive, 0–1= negative; P: t-test (2-tailed). BMI, body mass index; ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor 2.